The following is a summary of “Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using ...

The following is a summary of “Effect of disopyramide therapy on functional capacity improvement in patients with obstructive ...

Hypertrophic cardiomyopathy is the most common form of genetic heart disease worldwide. Researchers have estimated that up to 1 in 200 people have the condition, which is characterized by an ...

Dr. med. Ulrich Laufs, PD Dr. med. Karsten Lenk 1. Maron BJ, Epstein SE: Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979; 43: 1242–4 CrossRef MEDLINE 2. Members WC ...

Background: Symptoms are among the most important factors impacting quality of life (QOL) in hypertrophic cardiomyopathy (HCM) patients, and reflect a poor prognosis. Whether emotional stress can ...

Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disease marked by left ventricular hypertrophy, often due ...

A study has found that there are similar safety profiles for -blockers and verapamil in patients with low-risk hypertrophic ...

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disorder with around 85% of people with HCM remaining undiagnosed. There are no treatments approved for nonobstructive HCM ...

This Christmas, two Chicago sisters will celebrate with grateful hearts, bonded not only by family ties but by a shared ...

H.C. Wainwright analyst Joseph Pantginis has maintained their bullish stance on TNYA stock, giving a Buy rating today.Pick the best stocks and ...